Tenofovir: all 281 studies that test it
Page 1 of 3. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIVNot yet recruitingNCT07673965Phase 4
- Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir RegimensNot yet recruitingNCT07631897Phase 4
- Efficacy and Safety of Doravirine in the Rapid InitiationRecruitingNCT07357584Phase 4
- Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTIRecruitingNCT06602622Phase 4
- Antiviral Clinical Trial for Long Covid-19RecruitingNCT06511063Phase 2
- Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's DiseaseRecruitingNCT06356662Phase 1
- Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV VirusesNot yet recruitingNCT06338826Phase 2
- DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionRecruitingNCT06203132Phase 3
- Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan AfricaNot yet recruitingNCT06133686Phase 3
- Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized StudyRecruitingNCT05652478Phase 2
- HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.RecruitingNCT04640129Phase 4
- Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based BiosensorCompletedNCT04870671Early Phase 1Results posted
- Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGWCompletedNCT04760691Phase 1Results posted
- Open Label Extension (OLE) of the TDF2 Study, BotswanaCompletedNCT04318210Not applicableResults posted
- Biomarkers for Event-driven PrEP AdherenceCompletedNCT04298697Phase 4Results posted
- Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender WomenCompletedNCT04283656Phase 1Results posted
- Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone TherapyCompletedNCT04050371Phase 4Results posted
- Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI TractCompletedNCT03917420Phase 1Results posted
- Arresting Vertical Transmission of Hepatitis B VirusCompletedNCT03567382Phase 4Results posted
- A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral DrugsCompletedNCT03537404Phase 1Results posted
- DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP AdherenceCompletedNCT03387462Phase 4Results posted
- A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis BCompletedNCT03258710Phase 4Results posted
- ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-AdherenceCompletedNCT03218592Phase 4Results posted
- IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration ProjectCompletedNCT03058835Phase 4Results posted
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionTerminatedNCT02738008Phase 2Results posted
- Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIVCompletedNCT02495779Not applicableResults posted
- Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus InfectionTerminatedNCT02479880Phase 4Results posted
- Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)CompletedNCT02403674Phase 3Results posted
- Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)CompletedNCT02397096Phase 3Results posted
- Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated CirrhosisCompletedNCT02224456Phase 4Results posted
- Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS StudyCompletedNCT02195518Phase 4Results posted
- Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ARTCompletedNCT01903031Phase 2Results posted
- FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral ReservoirCompletedNCT01777997Phase 4Results posted
- Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in ThailandCompletedNCT01745822Phase 3Results posted
- Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning ServicesCompletedNCT01691768Phase 2/3Results posted
- Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B InfectionActive, not recruitingNCT01651403Phase 3Results posted
- Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively TreatedCompletedNCT01529749Phase 4Results posted
- Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCompletedNCT01525628Phase 1Results posted
- Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk WomenCompletedNCT01505114Phase 2Results posted
- Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid AnalogueCompletedNCT01480284Phase 3Results posted
- Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other DrugsCompletedNCT01475851Phase 3Results posted
- Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) SheddingCompletedNCT01448616Phase 4Results posted
- Bone, Immunologic, and Virologic Effects of a Antiretroviral RegimenCompletedNCT01400412Phase 2Results posted
- Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral SuppressionCompletedNCT01387022Not applicableResults posted
- Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis BCompletedNCT01369212Phase 3Results posted
- Drug Drug Interaction of BI 201335 and TenofovirCompletedNCT01340196Phase 1Results posted
- Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)CompletedNCT01300234Phase 3Results posted
- Comparative Safety Study of Two Vaginal Applicators With TenofovirCompletedNCT01283555Not applicableResults posted
- Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis BCompletedNCT01277601Phase 4Results posted
- Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected PatientsCompletedNCT01270802Phase 4Results posted
- Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV InfectionCompletedNCT01232127Phase 4Results posted
- Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous TreatmentCompletedNCT01063036Phase 3Results posted
- HIV Persistence and Viral ReservoirsCompletedNCT01025427Phase 4Results posted
- Artery Elasticity After Switch From Epzicom to TruvadaTerminatedNCT00998582Phase 4Results posted
- A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or BothCompletedNCT00962871Phase 1Results posted
- Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIVCompletedNCT00949234Phase 2Results posted
- Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)CompletedNCT00928187Phase 3Results posted
- Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)CompletedNCT00924898Phase 4Results posted
- Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy WomenCompletedNCT00869960Phase 4Results posted
- Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to LamivudineCompletedNCT00737568Phase 3Results posted
- A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B InfectionCompletedNCT00736190Phase 4Results posted
- Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B InfectionCompletedNCT00734162Phase 3Results posted
- Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in WomenCompletedNCT00705679Phase 2Results posted
- Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive SubjectsCompletedNCT00654147Phase 2Results posted
- The Effect of Raltegravir on HIV Decay During Primary and Chronic InfectionCompletedNCT00641641Not applicableResults posted
- Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected AdultsCompletedNCT00608569Not applicableResults posted
- A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B InfectionTerminatedNCT00605384Phase 3Results posted
- Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected WomenCompletedNCT00592124Phase 2Results posted
- Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant CouplesCompletedNCT00557245Phase 3Results posted
- Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected ChildrenCompletedNCT00528957Phase 3Results posted
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis BTerminatedNCT00524173Phase 2Results posted
- Botswana TDF/FTC Oral HIV Prophylaxis TrialCompletedNCT00448669Phase 2/3Results posted
- Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 InfectionCompletedNCT00414518Not applicableResults posted
- Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant VirusCompletedNCT00410202Phase 3Results posted
- Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis BCompletedNCT00410072Phase 3Results posted
- Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral TherapyCompletedNCT00352053Phase 3Results posted
- Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir DipivoxilCompletedNCT00307489Phase 2Results posted
- Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.CompletedNCT00298363Phase 2Results posted
- Viral Dynamics and Pharmacokinetics of Abacavir and TenofovirCompletedNCT00214890Phase 2Results posted
- Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative MenCompletedNCT00131677Phase 2Results posted
- Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, ThailandCompletedNCT00119106Phase 2/3Results posted
- Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected SubjectsCompletedNCT00112047Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)CompletedNCT00100048Phase 2Results posted
- Nine Month Course of Anti-HIV Medications for People Recently Infected With HIVTerminatedNCT00090779Phase 2Results posted
- Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedNCT00074581Phase 3Results posted
- Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIVCompletedNCT00035932Phase 3Results posted
- Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South AfricaActive, not recruitingNCT07006246Phase 4
- Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIVActive, not recruitingNCT06799650Phase 2
- To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901CompletedNCT06171880Phase 1
- Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South AfricaActive, not recruitingNCT06138600Phase 3
- The COMBAT HBV Feasibility TrialCompletedNCT05705427Phase 4
- Project Engage: Oral PrEP AcceptabilityCompletedNCT05458765Phase 2
- Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant WomenActive, not recruitingNCT05403047Phase 4
- Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in SerumCompletedNCT05355467Phase 4
- Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis BCompletedNCT05286346Phase 4
- A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis BCompletedNCT05282407Phase 4
- A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy SubjectsCompletedNCT05137548Phase 1
- Stop Hep B @ BirthStatus unknownNCT04998838Not applicable
- Reducing Vertical Transmission of Hepatitis B in AfricaActive, not recruitingNCT04704024Phase 3
- Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged HomeCompletedNCT04685512Phase 2/3